At the symposium, Chairman Shi Yuanyuan warmly welcomed the arrival of President Xing Jianwu and his delegation, and introduced in detail the development prospects of the cell and gene therapy industry, as well as the platform construction, core technical advantages, clinical application progress of cell products and major research and development breakthroughs of Shenzhen Cell Valley. Vice President Wang Huirui introduced to the Cell Valley team the overall construction and development of the Second Affiliated Hospital of Henan University of Science and Technology, the clinical progress and clinical application of cell therapy in the department. Chairman Shiyuan said that Shenzhen Cell Valley based on retroviral vector CAR-T, CAR-NK and TCR-T cell products through the unique and only domestic production process (PackRV-SS system) for pharmaceutical companies and medical institutions to achieve low-cost and high-quality industrial production provides solid technical support. Recently, the R&D team of Shenzhen Cell Valley has made breakthrough progress in the preparation process of CAR-NK and CAR-γδT cells, which will promote a number of innovative cell products to clinical application and commercial market, at the same time, after strict clinical trials and verification, a number of cell products have successfully entered the clinical application stage, and achieved remarkable results. Shenzhen Cell Valley will continue to deepen the research and development in the field of cell and gene therapy, not only in the platform construction, product research and development, personnel training and other links to achieve comprehensive development, but also actively promote the clinical transformation of scientific research results, and strive to provide patients with more safe and efficient treatment programs.

President Xing Jianwu highly appreciated Shenzhen Cell Valley's profound technical heritage and achievements in clinical treatment. He also said that the Second Affiliated Hospital of Henan University of Science and Technology has continuously made breakthroughs in the clinical treatment of blood diseases such as leukemia and aplastic anemia, and has always paid great attention to the development of cell therapy technology, hoping to carry out in-depth cooperation with Shenzhen Cell Valley in scientific research construction, clinical application and personnel training. Jointly promote the innovation and development of cell therapy technology.

The two sides conducted in-depth discussions on the platform construction plan, government policy support, and joint training of talents for the cooperation in building a cell therapy center, laying a good foundation for the subsequent joint construction of a high-level cell therapy center, and jointly providing patients with more high-quality, accurate and efficient medical services.